Cypress Bioscience

SAN DIEGO, CA -- (Marketwire) -- 11/09/10 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced financial results for the third quarter of 2010. The Company reported total revenue of $8.0 million for the quarter ended September 30, 2010, which includes commercial revenues of $7.2 million and revenues under collaborative agreement of $0.8 ... read more

SAN DIEGO, CA -- (Marketwire) -- 08/17/10 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced that its Board of Directors has sent a letter to Ramius LLC in response to Ramius' letter dated August 11, 2010. The text of the letter to Jeffrey C. Smith, Partner Managing Director of ... read more

SAN DIEGO, CA -- (Marketwire) -- 08/10/10 -- Cypress Bioscience, Inc. (NASDAQ: CYPB), a pharmaceutical company engaged in the development of innovative drugs to treat central nervous system disorders, today announced that it has received written notice of consent and effectiveness from the Office of Chief Scientist of ... read more

SAN DIEGO, CA -- (Marketwire) -- 08/09/10 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced financial results for the second quarter of 2010. The Company reported total revenue of $9.1 million for the quarter ended June 30, 2010, which includes commercial revenues of $8.1 million and revenues under collaborative ... read more

SAN DIEGO, CA -- (Marketwire) -- 08/04/10 -- Cypress Bioscience, Inc. (NASDAQ: CYPB), a pharmaceutical company engaged in the development of innovative drugs to treat central nervous system disorders, today announced that it is discontinuing its rights under its agreement with Forest Laboratories to co-promote Savella®, its drug ... read more

SAN DIEGO, CA -- (Marketwire) -- 05/10/10 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced financial results for the first quarter of 2010. The Company reported total revenue of $8.1 million for the quarter ended March 31, 2010, which includes commercial revenues of $7.1 million and revenues under ... read more

SAN DIEGO, CA -- (Marketwire) -- 03/31/10 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced financial results for the quarter and year ended December 31, 2009. The Company reported total revenue of $8.1 million for the quarter ended December 31, 2009, which includes commercial revenues of $7.0 million and revenues under collaborative ... read more

SAN DIEGO, CA -- (Marketwire) -- 11/09/09 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced financial results for the third quarter of 2009. The Company reported total revenue of $6.1 million for the quarter ended September 30, 2009, which includes commercial revenue of $5.2 million and revenues under collaborative agreement of $0.8 ... read more

SAN DIEGO, CA -- (Marketwire) -- 08/10/09 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced financial results for the second quarter of 2009. The Company reported total revenue of $5.8 million for the quarter ended June 30, 2009, which includes commercial revenue of $4.8 million and revenues under collaborative agreement of $0.9 ... read more

SAN DIEGO, CA -- (Marketwire) -- 05/11/09 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced financial results for the first quarter of 2009. For the quarter ended March 31, 2009, the Company reported a net loss of $9.2 million or $0.24 per share compared to a net loss of $2.9 million ... read more

SAN DIEGO, CA -- (Marketwire) -- 03/16/09 -- Cypress Bioscience, Inc. (NASDAQ: CYPB) today announced financial results for the quarter and year ended December 31, 2008. For the quarter ended December 31, 2008, the Company reported a net loss of $7.2 million or $0.19 per share compared to net income of ... read more